Drug Shortage Report for KETAMINE HYDROCHLORIDE INJECTION USP

Last updated on 2025-09-13 History
Report ID 265725
Drug Identification Number 02246796
Brand name KETAMINE HYDROCHLORIDE INJECTION USP
Common or Proper name KETAMINE HYDROCHLORIDE INJECTION USP
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) KETAMINE
Strength(s) 50MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 10ML
ATC code N01AX
ATC description ANESTHETICS, GENERAL
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2025-08-22
Actual start date
Estimated end date 2025-09-12
Actual end date 2025-09-12
Shortage status Resolved
Updated date 2025-09-13
Company comments Stock available at wholesalers
Health Canada comments
Tier 3 Status No
Contact Address 4600 RUE ARMAND-FRAPPIER
SAINT-HUBERT, QUEBEC
CANADA J3Z 1G5
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2025-09-13 English Compare
v7 2025-09-12 French Compare
v6 2025-09-12 English Compare
v5 2025-09-02 French Compare
v4 2025-09-02 English Compare
v3 2025-08-23 English Compare
v2 2025-08-21 French Compare
v1 2025-08-21 English Compare

Showing 1 to 8 of 8